Drug interactions
Linagliptin-metformin + Somapacitan
Severity: Moderate
Linagliptin-metformin and Somapacitan: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Growth hormone analogues reduce insulin sensitivity and can raise blood glucose. In patients taking antidiabetic drugs, this may weaken glycemic control and unmask or worsen diabetes.
What this interaction means in plain words
Linagliptin-metformin and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Linagliptin-metformin belongs to Endocrine; Somapacitan belongs to Endocrine.
Why it happens
Growth hormone induces insulin resistance, pharmacodynamically opposing the glucose-lowering effects of metformin and linagliptin.
What to do
Monitor fasting and postprandial glucose and HbA1c after starting somapacitan or changing its dose. Increase the antidiabetic regimen if glycemic control worsens.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin-metformin and Somapacitan, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Somapacitan
- Alogliptin-metformin + Somapacitan Moderate
- Alogliptin-pioglitazone + Somapacitan Moderate
- Alogliptin + Somapacitan Moderate
- Bazedoxifene-conjugated estrogens + Somapacitan Moderate
- Canagliflozin-metformin + Somapacitan Moderate
- Chlorpropamide + Somapacitan Moderate
Frequently asked questions
Can I take Linagliptin-metformin with Somapacitan?
MediHelp rates the interaction as moderate. Linagliptin-metformin and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone analogues reduce insulin sensitivity and can raise blood glucose. In patients taking antidiabetic drugs, this may weaken glycemic control and unmask or worsen diabetes.
How serious is the interaction between Linagliptin-metformin and Somapacitan?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor fasting and postprandial glucose and HbA1c after starting somapacitan or changing its dose. Increase the antidiabetic regimen if glycemic control worsens.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
